Warfarin
Back to searchMolecule Structure
Scientific Name
Warfarin
Description of the Drug
Warfarin is a vitamin K antagonist used to treat venous thromboembolism, pulmonary embolism, thromboembolism with atrial fibrillation, thromboembolism with cardiac valve replacement, and thromboembolic events post myocardial infarction.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00682
http://www.drugbank.ca/drugs/DB00682
Brand Name(s)
Not Available
Company Owner(s)
Usl Pharma Inc, Pharmaceutical Research Assoc Inc, Pliva Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Abbott Laboratories Pharmaceutical Products Div, Chartwell Rx Sciences Llc, Upsher Smith Laboratories Llc, Ipca Laboratories Ltd, Amneal Pharmaceuticals
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Vitamin k epoxide reductase complex subunit 1 isoform 1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1930 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3689 | ||||
| Human Metabolome Database | HMDB0001935 | ||||
| DrugBank | DB00682 | ||||
| PubChem: Thomson Pharma | 14825580 | ||||
| PubChem | 54678486 | ||||
| Mcule | MCULE-1618253893 | ||||
| LINCS | LSM-1405 | ||||
| Nikkaji | J3.862H | ||||
| BindingDB | 50343352 | ||||
| EPA CompTox Dashboard | DTXSID5023742 | ||||
| DrugCentral | 2847 | ||||
| Brenda | 75368 | 78827 | 719 | 75367 | 132281 |
| Guide to Pharmacology | 6853 | ||||
| rxnorm | COUMADIN | WARFARIN POTASSIUM | WARFARIN SODIUM | JANTOVEN | WARFARIN |
| KEGG Ligand | C01541 | ||||
| ChEBI | 87732 |
